Cyxone AB (OSTO:CYXO) Days Payable : 0.00 (As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Cyxone AB Days Payable?

Cyxone AB's average Accounts Payable for the three months ended in Jun. 2024 was kr1.74 Mil. Cyxone AB's Cost of Goods Sold for the three months ended in Jun. 2024 was kr-0.37 Mil.

The historical rank and industry rank for Cyxone AB's Days Payable or its related term are showing as below:

OSTO:CYXO's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 121.27
* Ranked among companies with meaningful Days Payable only.

Cyxone AB's Days Payable stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00). stayed the same

Cyxone AB Days Payable Historical Data

The historical data trend for Cyxone AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyxone AB Days Payable Chart

Cyxone AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

Cyxone AB Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cyxone AB's Days Payable

For the Biotechnology subindustry, Cyxone AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyxone AB's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cyxone AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Cyxone AB's Days Payable falls into.

Save Embed

;

Save Embed

;

Cyxone AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Cyxone AB's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (1.842	+	1.827)	/	2 )	/	0	*	365
=	1.8345					/	0	*	365
=	N/A

Cyxone AB's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2024 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (2.333	+	1.145)	/	2 )	/	-0.367	*	365 / 4
=	1.739					/	-0.367	*	365 / 4
=	N/A

Cyxone AB Days Payable Related Terms

Thank you for viewing the detailed overview of Cyxone AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyxone AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyxone AB (OSTO:CYXO) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hyllie Boulevard 34, Malmo, SWE, 215 32

Website

https://www.cyxone.com

Cyxone AB is a clinical biotech company with a portfolio of immunomodulating drugs for the treatment of autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). The product candidates of the company include T20K and Rabeximod.

Cyxone AB Headlines

No Headlines